Diffusion weighted imaging in prostate cancer
- PMID: 20936413
- DOI: 10.1007/s00330-010-1960-y
Diffusion weighted imaging in prostate cancer
Abstract
Diffusion-weighted imaging has generated substantial interest in the hope that it can be developed into a robust technique to improve the accuracy of MRI for the evaluation of prostate cancer. This technique has the advantages of short acquisition times, no need for intravenous administration of contrast medium, and the ability to study diffusion of water molecules that indirectly reflects tissue cellularity. In this article, we review the existing literature on the utility of DWI in tumour detection, localisation, treatment response, limitations of the technique, how it compares with other imaging techniques, technical considerations and future directions.
Similar articles
-
Clinical utility of diffusion-weighted magnetic resonance imaging in prostate cancer.BJU Int. 2011 Dec;108(11):1716-22. doi: 10.1111/j.1464-410X.2011.10256.x. Epub 2011 Jun 1. BJU Int. 2011. PMID: 21631696 Review.
-
MR-perfusion (MRP) and diffusion-weighted imaging (DWI) in prostate cancer: quantitative and model-based gadobenate dimeglumine MRP parameters in detection of prostate cancer.Eur J Radiol. 2010 Dec;76(3):359-66. doi: 10.1016/j.ejrad.2010.04.023. Epub 2010 May 14. Eur J Radiol. 2010. PMID: 20471189
-
Quantitative diffusion-weighted imaging and dynamic contrast-enhanced characterization of the index lesion with multiparametric MRI in prostate cancer patients.J Magn Reson Imaging. 2017 Mar;45(3):908-916. doi: 10.1002/jmri.25391. Epub 2016 Jul 21. J Magn Reson Imaging. 2017. PMID: 27442039
-
Prostate cancer: utility of diffusion-weighted imaging as a marker of side-specific risk of extracapsular extension.J Magn Reson Imaging. 2013 Aug;38(2):312-9. doi: 10.1002/jmri.23972. Epub 2012 Dec 12. J Magn Reson Imaging. 2013. PMID: 23238968
-
Diffusion-weighted MRI and its role in prostate cancer.NMR Biomed. 2014 Jan;27(1):25-38. doi: 10.1002/nbm.2956. Epub 2013 May 27. NMR Biomed. 2014. PMID: 23712781 Review.
Cited by
-
Can diffusion-weighted magnetic resonance imaging predict a high Gleason score of prostate cancer?Korean J Urol. 2013 Apr;54(4):234-8. doi: 10.4111/kju.2013.54.4.234. Epub 2013 Apr 16. Korean J Urol. 2013. PMID: 23614059 Free PMC article.
-
Prospective comparison of PI-RADS version 2 and qualitative in-house categorization system in detection of prostate cancer.J Magn Reson Imaging. 2018 Nov;48(5):1326-1335. doi: 10.1002/jmri.26025. Epub 2018 Mar 31. J Magn Reson Imaging. 2018. PMID: 29603833 Free PMC article.
-
DCE MRI of prostate cancer.Abdom Radiol (NY). 2016 May;41(5):844-53. doi: 10.1007/s00261-015-0589-3. Abdom Radiol (NY). 2016. PMID: 27193787 Free PMC article. Review.
-
Advances in imaging and in non-surgical salvage treatments after radiorecurrence in prostate cancer: what does the oncologist, radiotherapist and radiologist need to know?Eur Radiol. 2012 Dec;22(12):2848-58. doi: 10.1007/s00330-012-2546-7. Epub 2012 Jul 14. Eur Radiol. 2012. PMID: 22797953 Review.
-
Potential of hybrid ¹⁸F-fluorocholine PET/MRI for prostate cancer imaging.Eur J Nucl Med Mol Imaging. 2014 Sep;41(9):1744-55. doi: 10.1007/s00259-014-2786-7. Epub 2014 May 20. Eur J Nucl Med Mol Imaging. 2014. PMID: 24841413
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical